ReviewFrontiers in pediatrics2025
Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near.
Gilda M Portalatin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it